Atlas Trials

Study To Determine The Effects Of Doses Of Relacatib On The Metabolism Of Acetaminophen, Ibuprofen And Atorvastatin

Clinical trial NCT00411190 · COMPLETED

Trial details

NCT number
NCT00411190
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Osteoarthritis
Start date
2006-10-19
Primary completion
2006-12-15
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.